Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.75
Bid: 18.35
Ask: 19.80
Change: 0.10 (0.51%)
Spread: 1.45 (7.902%)
Open: 19.75
High: 19.75
Low: 19.75
Prev. Close: 19.65
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

1 Feb 2021 07:00

RNS Number : 4589N
BATM Advanced Communications Ld
01 February 2021
 

LEI: 213800FLQUB9J289RU66

1 February 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Trading Update and Notice of Results

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, provides the following update on trading for the year ended 31 December 2020 ahead of announcing its annual results on Monday 22 February 2021.

 

As stated in the interim results announcement, the Group entered the second half of 2020 with a substantially higher backlog than at the same point in the prior year. This momentum continued through the second half, with stronger than anticipated demand for the Group's diagnostics solutions towards the end of the year as the second wave of the COVID-19 pandemic spread across the globe. Consequently, BATM expects revenue for full year 2020 to be at least $180m - significantly ahead of the upgraded market expectations - representing annual growth of over 45% and, consequently, EBITDA to be substantially ahead of market expectations.

 

The substantial growth over the previous year was driven by the Bio-Medical division. In particular, the Diagnostics unit rapidly developed testing kits in response to the outbreak of COVID-19 and received strong demand throughout the year for its reagents and instruments. These sales were primarily to public health authorities in Europe and South East Asia, and the Group has continued to receive significant orders for its diagnostic solutions into 2021. The Eco-Med unit also contributed to the exceptional performance of the Bio-Medical division in 2020 with the manufacture of critical care ventilators.

 

The Networking & Cyber division remained resilient despite the restrictions on travel and ability to install equipment in customers' premises due to global lockdowns. In addition, the Group continued to make significant progress with its network function virtualisation ("NFV") solution - which the Group expects to become a key growth engine of the business - securing its first tier 1 customer for NFVTime with a three-year licensing agreement and conducting several successful proofs-of-concept with tier 1 operators in Europe and APAC, including Vodafone.

The Group will provide further detail in its full year results announcement.

 

Full Year Results Presentation

 

Dr Zvi Marom, Chief Executive Officer, and Moti Nagar, Chief Financial Officer, will be hosting a presentation via webinar for investors and analysts at 2.00pm GMT on Monday 22 February 2021. To register to participate, please contact clairenorbury@luther.co.uk

 

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFLILEILVIL
Date   Source Headline
16th Dec 201012:57 pmRNSHolding(s) in Company
29th Nov 201011:30 amRNSDirectorate Change
10th Nov 20107:00 amRNSTrading Statement
28th Sep 20107:00 amRNSContract Win
13th Sep 20107:00 amRNSInterim Management Statement
10th Aug 20107:00 amRNSHalf Yearly Report
5th Aug 20107:00 amRNSInvestor Day
28th Jul 20107:00 amRNSNotice of Interim Results
28th Jun 20108:58 amRNSDirectorate Change
22nd Jun 201012:53 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAGM Statement
14th Jun 20102:04 pmRNSHolding(s) in Company
2nd Jun 20102:50 pmRNSAnnual Information Update
20th May 201011:00 amRNSHolding(s) in Company
18th May 20104:25 pmRNSDirector/PDMR Shareholding
18th May 201011:24 amRNSDirector/PDMR Shareholding
18th May 20107:00 amRNSInterim Management Statement
12th May 20102:48 pmRNSNotice of IMS
30th Apr 20104:00 pmRNSAnnual Financial Report
22nd Apr 20107:00 amRNSLicensing Agreement
15th Mar 201010:47 amRNSHolding(s) in Company
15th Mar 201010:43 amRNSHolding(s) in Company
22nd Feb 201012:58 pmRNSDirector/PDMR Shareholding
18th Feb 20104:31 pmRNSHolding(s) in Company
9th Feb 20103:04 pmRNSDirector/PDMR Shareholding
8th Feb 201010:10 amRNSHolding(s) in Company
8th Feb 20107:00 amRNSFinal Results
1st Feb 201010:27 amRNSHolding(s) in Company
28th Jan 201010:00 amRNSNotice of Results
4th Jan 20109:01 amRNSHolding(s) in Company
16th Dec 20097:00 amRNSContract to develop & supply military comms
4th Dec 20099:27 amRNSHolding(s) in Company
29th Oct 20097:00 amRNSInterim Management Statement
19th Oct 200912:00 pmRNSDirector/PDMR Shareholding
19th Oct 200911:54 amRNSHolding(s) in Company
19th Oct 200911:54 amRNSHolding(s) in Company
15th Oct 20092:54 pmRNSDirector/PDMR Shareholding
26th Aug 20091:31 pmRNSDirector/PDMR Shareholding
20th Aug 20092:43 pmRNSHolding(s) in Company
13th Aug 20093:36 pmRNSDirector/PDMR Shareholding
4th Aug 20097:00 amRNSHalf Yearly Report
15th Jul 200910:00 amRNSNotice of Results
22nd Jun 20093:42 pmRNSResult of AGM
17th Jun 20097:00 amRNSAGM Statement
10th Jun 200911:37 amRNSHolding(s) in Company
19th May 20093:28 pmRNSAnnual Information Update
14th May 200911:34 amRNSDirector/PDMR Shareholding
12th May 20097:00 amRNSInterim Management Statement
30th Apr 20092:00 pmRNSAnnual Financial Report
31st Mar 20097:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.